Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ANI Pharmaceuticals Inc (NASDAQ:ANIP)

63.17
Delayed Data
As of Aug 26
 +0.30 / +0.48%
Today’s Change
26.80
Today|||52-Week Range
70.92
+39.99%
Year-to-Date
Mallinckrodt DMD Drug Gets Fast Track Status in the U.S.
Aug 26 / Zacks.com - Paid Partner Content
Aclaris (ACRS) Common Warts Candidate Positive in Phase II
Aug 19 / Zacks.com - Paid Partner Content
Vanda Stock Up on Favorable U.S. Court Ruling for Fanapt
Aug 26 / Zacks.com - Paid Partner Content
FDA OKs Edwards Lifesciences' Sapien 3 for Extended Use
Aug 19 / Zacks.com - Paid Partner Content
Amgen Gets CRL for Secondary Hyperparathyroidism Drug
Aug 25 / Zacks.com - Paid Partner Content
Intercept (ICPT) Ocaliva Phase III POISE Data Published
Aug 18 / Zacks.com - Paid Partner Content
Mylan (MYL) Obtains Favorable USPTO Ruling for Copaxone
Aug 25 / Zacks.com - Paid Partner Content
Cerulean (CERU) Kidney Cancer Drug Disappoints in Phase II
Aug 18 / Zacks.com - Paid Partner Content
Kindred Biosciences (KIN) Jumps: Stock Moves 5.7% Higher
Aug 25 / Zacks.com - Paid Partner Content
Portola (PTLA) Stock Down on CRL for AndexXa BLA in U.S.
Aug 18 / Zacks.com - Paid Partner Content
Urban Outfitters, Fogo de Chao, Oclaro, ANI Pharmaceuticals and FormFactor highlighte...
Aug 24 / Zacks.com - Paid Partner Content
Why ANI Pharmaceuticals (ANIP) Could Be Positioned for a Surge?
Aug 18 / Zacks.com - Paid Partner Content
Mylan (MYL) Draws Flak for Over Pricing EpiPen, Stock Down
Aug 24 / Zacks.com - Paid Partner Content
Sunesis Pharmaceuticals (SNSS) Jumps: Stock Rises 23.1%
Aug 18 / Zacks.com - Paid Partner Content
Pfizer to Acquire Rights to AstraZeneca's Antibiotics Business
Aug 24 / Zacks.com - Paid Partner Content
Align Technology's Invisalign Dependence: Boon or Curse?
Aug 17 / Zacks.com - Paid Partner Content
Clovis (CLVS) Stock Up on FDA Priority Review for Rucaparib
Aug 24 / Zacks.com - Paid Partner Content
FDA Approves Edwards Lifesciences' Intuity Elite Heart Valve
Aug 17 / Zacks.com - Paid Partner Content
3 Small-Cap Stocks With Sky-High Growth Potential
Aug 23 / Zacks.com - Paid Partner Content
OncoGenex Down on Poor Phase III Data on Lead Cancer Drug
Aug 17 / Zacks.com - Paid Partner Content
Regeneron Stock Up on BARDA Deal for MERS Antibodies
Aug 23 / Zacks.com - Paid Partner Content
How ANI Pharmaceuticals (ANIP) Stock Stands Out in a Strong Industry
Aug 17 / Zacks.com - Paid Partner Content
Roche Launches Accu-Chek Blood Glucose Monitoring System
Aug 23 / Zacks.com - Paid Partner Content
Syros Pharmaceuticals (SYRS) Jumps: Stock Moves Up 36.1%
Aug 17 / Zacks.com - Paid Partner Content
Puma (PBYI) Neratinib's Application Validated in EU, Stock Up
Aug 23 / Zacks.com - Paid Partner Content
Inovio (INO) Veterinary Vaccine Rights Licensed to Plumbline
Aug 17 / Zacks.com - Paid Partner Content
Galapagos (GLPG) Advances RA Drug Filgotinib to Phase III
Aug 23 / Zacks.com - Paid Partner Content
Radius (RDUS) Osteoporosis Drug Positive in Phase III Study
Aug 17 / Zacks.com - Paid Partner Content
Zacks.com featured highlights: ANI Pharmaceuticals, Cooper-Standard Holdings, Berry P...
Aug 23 / Zacks.com - Paid Partner Content
Actelion (ALIOF) Uptravi Approved for PAH in Switzerland
Aug 17 / Zacks.com - Paid Partner Content
Supernus' Trokendi XR Gets FDA Nod for Migraine in Adults
Aug 22 / Zacks.com - Paid Partner Content
Aurinia (AUPH) Stock Falls on Poor Phase II Lupus Study Data
Aug 16 / Zacks.com - Paid Partner Content
7 High-Flying Stocks with More Room to Run
Aug 22 / Zacks.com - Paid Partner Content
Can The Uptrend Continue for ANI Pharmaceuticals (ANIP)?
Aug 16 / Zacks.com - Paid Partner Content
Editas Medicine (EDIT) in Focus: Stock Moves 5.1% Higher
Aug 22 / Zacks.com - Paid Partner Content
Repros Presents 6-Month Interim Data on Enclomiphene
Aug 16 / Zacks.com - Paid Partner Content
Xenetic's IND to Start Phase II Virexxa Study Accepted in U.S.
Aug 22 / Zacks.com - Paid Partner Content
UCB Epilepsy Drug Vimpat's Patent Validated by U.S. Court
Aug 16 / Zacks.com - Paid Partner Content
Portola IndexXa's Regulatory Application Validated in the EU
Aug 22 / Zacks.com - Paid Partner Content
Vertex (VRTX) To Stop VX-661-Ivacaftor Study, Stock Down
Aug 16 / Zacks.com - Paid Partner Content
Pfizer's (PFE) Pain Drug Troxyca ER Receives FDA Approval
Aug 22 / Zacks.com - Paid Partner Content
Myriad Genetics: Q4 Hit by Low Test Revenues, Gross Margin
Aug 16 / Zacks.com - Paid Partner Content
Horizon (HZNP) Rayos Receives USPTO Notice of Allowance
Aug 19 / Zacks.com - Paid Partner Content
Bristol-Myers to Reacquire Rights to Oncology Drug in Asia
Aug 15 / Zacks.com - Paid Partner Content